Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III long-term study of KRP-108 in pediatric bronchial asthma
jRCT2080223577Phase 3Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of evogrel in asthma, sponsored by Kyorin Pharmaceutical. Started Jun 2017; status: completed.
02
Drugs
evogrel
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080223577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223577.